Thyroid Hormones and Reproductive System Characteristics in Humans and Laboratory Animals

• Ammar Issa Taresh

  Department of Community Health Technical, Technical Institute of Basra, Southern Technical University

General Background: Thyroid hormones (THs) are vital for the development and function of various physiological systems, including the reproductive system, in both humans and animals. Specific Background: Disruptions in TH levels, due to disease or environmental toxicants, have been implicated in fertility issues, pregnancy outcomes, and postnatal development. Knowledge Gap: However, comparative data on how thyroid dysfunction affects human versus rodent reproduction remain limited, particularly concerning mechanistic pathways and developmental endpoints. Aim: This study aimed to evaluate and compare the effects of thyroid hormone imbalances on the reproductive systems of humans and laboratory animals, focusing on both genomic and nongenomic mechanisms. Results: Findings show that both hypothyroidism and hyperthyroidism disrupt reproductive hormone balance, gametogenesis, and sexual development, though the severity and pathways differ between species. Animal testing protocols revealed species-specific responses in thyroid hormone metabolism, signaling, and reproductive outcomes. Novelty: The research integrates genomic-nongenomic TH pathways, evaluates reproductive endpoints in endocrine-disruptor assays, and compares species-specific thyroid function. Implications: These findings underscore the importance of refining animal models and screening protocols for better prediction of human reproductive risks, advocating for inclusion of thyroid-sensitive parameters in regulatory toxicity assessments.
Highlight :

• Thyroid hormones play critical roles in reproductive system development in both humans and lab animals.

• Hypo- and hyperthyroidism significantly affect fertility, menstrual cycles, and hormonal balance.

• Rodent models offer insights but may not fully replicate human thyroid physiology.

Keywords : Thyroid Hormones, Reproduction, Hormone Receptors, Thyroid Dysfunction, Rodent Models

[1] S. A. Aboul-Khair, J. Crooks, A. C. Turnbull, and F. E. Hytten, “The Physiological Changes in Thyroid Function During Pregnancy,” Clin. Sci., vol. 27, pp. 195–207, 1964.

[2] J. Berglund, S. B. Christensen, and B. Hallengren, “Total and Age-Specific Incidence of Graves’ Thyrotoxicosis, Toxic Nodular Goitre and Solitary Toxic Adenoma in Malmo 1970–74,” J. Intern. Med., vol. 227, pp. 137–141, 1990.

[3] L. Skjoldebrand Sparre, M. Kollind, and K. Carlstrom, “Ovarian Ultrasound and Ovarian and Adrenal Hormones Before and After Treatment for Hyperthyroidism,” Gynecol. Obstet. Invest., vol. 54, pp. 50–55, 2002.

[4] L. Skjoldebrand, J. Brundin, A. Carlstrom et al., “Thyroid Associated Components in Serum During Normal Pregnancy,” Acta Endocrinol. (Copenh), vol. 100, pp. 504–511, 1982.

[5] Y. Q. Su, J. M. Denegre, K. Wigglesworth et al., “Oocyte-Dependent Activation of Mitogen-Activated Protein Kinase (ERK1/2) in Cumulus Cells Is Required for the Maturation of the Mouse Oocyte–Cumulus Cell Complex,” Dev. Biol., vol. 263, pp. 126–138, 2003.

[6] C. Sylven, E. Jansson, P. Sotonyi et al., “Cardiac Nuclear Hormone Receptor mRNA in Heart Failure in Man,” Life Sci., vol. 59, pp. 1917–1922, 1996.

[7] H. Y. Tang, H. Y. Lin, S. Zhang et al., “Thyroid Hormone Causes Mitogen-Activated Protein Kinase-Dependent Phosphorylation of the Nuclear Estrogen Receptor,” Endocrinology, vol. 145, pp. 3265–3272, 2004.

[8] R. Thomas and R. L. Reid, “Thyroid Disease and Reproductive Dysfunction: A Review,” Obstet. Gynecol., vol. 70, pp. 789–798, 1987.

[9] Y. Pirahanchi, F. Toro, and I. Jialal, “Physiology, Thyroid Stimulating Hormone,” StatPearls, Treasure Island, FL, USA, 2021.

[10] T. M. Ortiga-Carvalho, M. I. Chiamolera, C. C. Pazos-Moura, and F. E. Wondisford, “Hypothalamus-Pituitary-Thyroid Axis,” Compr. Physiol., vol. 6, pp. 1387–1428, 2016.

[11] D. Braun and U. Schweizer, “Thyroid Hormone Transport and Transporters,” Vitam. Horm., vol. 106, pp. 19–44, 2018.

[12] W. E. Visser, E. C. Friesema, J. Jansen, and T. J. Visser, “Thyroid Hormone Transport by Monocarboxylate Transporters,” Best Pract. Res. Clin. Endocrinol. Metab., vol. 21, pp. 223–236, 2007.

[13] R. M. Evans, “The Steroid and Thyroid Hormone Receptor Superfamily,” Science, vol. 240, pp. 889–895, 1988.

[14] J. F. Silva, N. M. Ocarino, and R. Serakides, “Thyroid Hormones and Female Reproduction,” Biol. Reprod., vol. 99, no. 5, pp. 907–921, 2018.

[15] Y. L. Guo, T. J. Lai, S. H. Ju, Y. C. Chen, and C. C. Hsu, “Sexual Developments and Biological Findings in Yucheng Children,” in Proc. 13th Int. Symp. Chlorinated Dioxins Relat. Compounds, Vienna, Austria, 1993, pp. 247–250.

[16] L. S. Birnbaum, “Endocrine Effects of Prenatal Exposure to PCBs, Dioxins, and Other Xenobiotics: Implications for Policy and Research,” Environ. Health Perspect., vol. 102, pp. 676–679, 1994.

[17] K. S. Khera and J. A. Ruddick, “Polychlorodibenzo-p-Dioxins: Perinatal Effects and the Dominant Lethal Test in Wistar Rats,” in Chlorodioxins—Origin and Fate, E. H. Blair, Ed. Washington, DC: American Chemical Society, 1973, pp. 70–84.

[18] F. J. Murray et al., “Three-Generation Reproduction Study in Rats Given 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) in the Diet,” Toxicol. Appl. Pharmacol., vol. 50, pp. 241–252, 1979.

[19] P. S. Cooke, “Thyroid Hormones and Testis Development: A Model System for Increasing Testis Growth and Sperm Production,” Ann. N. Y. Acad. Sci., vol. 637, pp. 122–132, 1991.

[20] F. R. Crantz and P. R. Larsen, “Rapid Thyroxine to 3,5,3’-Triiodothyronine Conversion and Nuclear 3,5,3’-Triiodothyronine Binding in Rat Cerebral Cortex and Cerebellum,” J. Clin. Invest., vol. 65, pp. 935–938, 1980.

[21] K. D. Dohler, C. C. Wong, and A. von zur Muhlen, “The Rat as Model for the Study of Drug Effects on Thyroid Function,” Pharmacol. Ther., vol. 5, pp. 305–318, 1979.

[22] J. D. Feldman, “Iodine Metabolism in Pregnancy,” Am. J. Physiol., vol. 192, pp. 273–278, 1958.

[23] K. A. B. Findlay, E. Kaptein, T. J. Visser, and B. Burchell, “Characterization of the Uridine Diphosphate-Glucuronosyltransferase-Catalyzing Thyroid Hormone Glucuronidation in Man,” J. Clin. Endocrinol. Metab., vol. 85, pp. 2879–2883, 2000.

[24] L. Baschieri, G. Benedetti, F. de Luca, and M. Negri, “Evaluation and Limitations of the Perchlorate Test in the Study of Thyroid Function,” J. Clin. Endocrinol. Metab., vol. 23, pp. 786–791, 1963.

[25] C. K. Atterwill et al., “The Perchlorate Discharge Test for Examining Thyroid Function in Rats,” J. Pharmacol. Methods, vol. 18, pp. 199–203, 1987.

[26] M. E. Morgans and W. R. Trotter, “Defective Organic Binding of Iodine by the Thyroid in Hashimoto's Thyroiditis,” Lancet, vol. 272, pp. 553–555, 1955.

[27] J. Wolff, “Perchlorate and the Thyroid Gland,” Pharmacol. Rev., vol. 50, pp. 89–105, 1998.

[28] D. H. Sarne and S. Refetoff, “Thyroid Function Tests,” in Endocrinology, L. J. DeGroot, Ed. Philadelphia, PA: WB Saunders Co., 1995, pp. 617–664.

[29] J. Hebert et al., “Transthyretin: A Choroid Plexus-Specific Transport Protein in Human Brain,” Neurology, vol. 36, pp. 900–911, 1986.

[30] A. Brouwer et al., “Competitive Inhibition of Thyroxine Binding to Transthyretin by Monohydroxy Metabolites of 3,4,3',4'-Tetrachlorobiphenyl,” Chemosphere, vol. 20, pp. 1257–1262, 1990.

[31] K. J. van den Berg et al., “Interactions of Halogenated Industrial Chemicals with Transthyretin and Effects on Thyroid Hormone Levels in Vivo,” Arch. Toxicol., vol. 65, pp. 15–19, 1991.

[32] J. D. McKinney and C. L. Waller, “Polychlorinated Biphenyls as Hormonally Active Structural Analogues,” Environ. Health Perspect., vol. 102, pp. 290–297, 1994.

[33] M. C. Lans, C. Spiertx, A. Brouwer, and J. H. Koeman, “Different Competition of Thyroxine Binding to Transthyretin and Thyroxine-Binding Globulin by Hydroxy-PCBs, PCDDs, and PCDFs,” Eur. J. Pharmacol., vol. 170, pp. 129–136, 1994.

[34] L. M. Ogilvie and D. B. Ramsden, “Ioxynil and 3,5,3'-Triiodothyronine: Comparison of Binding to Human Plasma Proteins,” Toxicol. Lett., vol. 44, pp. 281–287, 1988.

[35] A. O. Cheek, K. Kow, J. Chen, and J. A. McLachlan, “Potential Mechanisms of Thyroid Disruption in Humans,” Environ. Health Perspect., vol. 107, pp. 273–278, 1999.

[36] K. J. Gauger et al., “Polychlorinated Biphenyls (PCBs) Exert Thyroid Hormone-Like Effects in the Fetal Rat Brain but Do Not Bind to Thyroid Hormone Receptors,” Environ. Health Perspect., vol. 112, pp. 516–523, 2004.

[37] R. Bansal et al., “Maternal Thyroid Hormone Increases HES Expression in the Fetal Rat Brain,” Brain Res. Dev. Brain Res., vol. 156, pp. 13–22, 2005.

[38] R. T. Zoeller, A. L. Dowling, and A. A. Vas, “Developmental Exposure to Polychlorinated Biphenyls Exerts Thyroid Hormone-Like Effects,” Endocrinology, vol. 141, pp. 181–189, 2000.

[39] S. A. Roelens et al., “Neurotoxicity of Polychlorinated Biphenyls (PCBs) by Disturbance of Thyroid Hormone-Regulated Genes,” Ann. N. Y. Acad. Sci., vol. 1040, pp. 454–456, 2005.

[40] A. I. Loaiza-Perez et al., “Hexachlorobenzene Increases Malic Enzyme Gene Transcription via Thyroid Hormone Response Element,” Endocrinology, vol. 140, pp. 4142–4151, 1999.

[41] G. E. Krassas, “Thyroid Disease and Female Reproduction,” Fertil. Steril., vol. 74, pp. 1063–1070, 2000.

[42] G. E. Krassas, N. Pontikides, V. Deligianni, and K. Miras, “A Prospective Controlled Study of the Impact of Hyperthyroidism on Reproductive Function in Males,” J. Clin. Endocrinol. Metab., vol. 87, pp. 3667–3671, 2002.

[43] J. L. Leonard and J. Koehrle, “Intracellular Pathways of Iodothyronine Metabolism,” in Werner and Ingbar’s The Thyroid, 8th ed., L. E. Braverman and R. D. Utiger, Eds. Philadelphia: Lippincott Williams & Wilkins, 2000, pp. 136–173.

[44] L. Savu et al., “A Senescence Up-Regulated Protein: The Rat Thyroxine-Binding Globulin (TBG),” Biochim. Biophys. Acta, vol. 1097, pp. 19–22, 1991.

[45] G. Schneider et al., “The Hypothalamic-Pituitary-Gonadal Axis During Hyperthyroidism in the Rat,” Endocrinology, vol. 105, pp. 674–679, 1979.